HLTH: Adds Pharmacy to Care Platform

Cue now offers over-the-counter and prescription medications for sexual health, birth control, hair loss, and more

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with over-the-counter and prescription medication options for a growing number of common health and wellness needs. These include sexual health - such as erectile dysfunction and herpes - as well as birth control, hair loss, and more.

Building on last month’s launch of its new collection of consumer-friendly, at-home diagnostic test kits, as well as existing treatment options that Cue offers for infectious diseases including COVID-19, influenza, and urinary tract infections, the all-new pharmacy offering now provides individuals with a convenient and private way to manage a growing number of common health and wellness concerns.

“Many of the conditions for which we now offer care choices and medication often go ignored or unaddressed due to a gap in awareness or a lack of discreet access, which can lead to adverse health effects,” said Dr. David Tsay, Chief Medical Officer for Cue Health. “Integrating an all-new pharmacy experience within our diagnostic-enabled care platform is yet another example of how Cue is working to empower people to live their healthiest lives.”

Individuals can now utilize Cue to purchase over-the-counter medications either a la carte or by subscription, which they can manage by selecting their desired cadence. Customers can also choose to consult with a clinician to get advice or learn more about their condition and, if medically indicated, receive prescription medication in a dosage that’s right for them.

For a full list of Cue’s pharmacy options and information about the conditions that can be treated, please visit here .

About Cue Health

Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. The Cue Health platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point of care, as well as on-demand telehealth consultations and treatment options for a wide range of health and wellness needs. Cue’s customers include federal and state public sector agencies and the private sector, which includes healthcare providers, enterprises, and individual consumers. Cue’s COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription. Cue has since received Emergency Use Authorization from the FDA for its molecular mpox test at the point of care and, to expand its test menu, the company has a number of other submissions under review by the FDA. Cue, founded in 2010, owns over 100 patents and is headquartered in San Diego. For more information, please visit www.cuehealth.com .